Multidrug resistance and anticonvulsants: New studies with some enaminones

Current Medicinal Chemistry

Volumn 11, Issue 15, 2004, Pages 2093-2103

  Salama, Noha Nabil ^a   Eddington, Natalie D ^a   Payne, Debra ^b   Wilson, Tiffany L ^b   Scott, K R ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF PHARMACY   (United States)

^b HOWARD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 BIS(ALLYLAMINO) 6 [4 [[2,2 BIS(4 FLUOROPHENYL)ETHYL]AMINO]PIPERIDINO] 1,3,5 TRIAZINE; 2,4 DINITROPHENOL; 2,4 DINITROPHENOL S GLUTATHIONE; 3 [N (4 CHLOROPHENYL)AMINO] 2 CYCLOHEXENONE; 3,5 DINITROPHENOL; ANTICONVULSIVE AGENT; BIRICODAR; CARRIER PROTEIN; CYCLOSPORIN A; DAUNORUBICIN; ELACRIDAR; ENAMINONE DERIVATIVE; ETHYL 4 [(5 METHYL 3 ISOXAZOLY)AMINO] 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; FLUNITRAZEPAM; GLYCOPROTEIN P; METHYL 4 (3 NITROPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; METHYL 4 (3 TRIFLUOROMETHOXYPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; METHYL 4 (4 CHLOROPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; METHYL 4 (4 CYANOPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; METHYL 4 (4 PHENYLBUTYLPHENYLAMINO) 6 METHYL 2 OXOCYCLOHEX 3 ENYLCARBOXYLATE; MULTIDRUG RESISTANCE PROTEIN; NEW DRUG; NIFEDIPINE; PACLITAXEL; PROBENECID; QUINIDINE; SULFINPYRAZONE; TRIFLUOPERAZINE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VERAPAMIL;

ANTICONVULSANT THERAPY; CANCER CELL; CLINICAL TRIAL; DRUG BIOAVAILABILITY; DRUG BRAIN LEVEL; DRUG CYTOTOXICITY; DRUG DISTRIBUTION; DRUG POTENTIATION; DRUG RELEASE; DRUG STRUCTURE; DRUG TARGETING; EPILEPSY; HUMAN; MULTIDRUG RESISTANCE; NONHUMAN; REVIEW; STRUCTURE ACTIVITY RELATION;

EID: 3242804613     PISSN: 09298673     EISSN: None     Source Type: Journal    
DOI: 10.2174/0929867043364766     Document Type: Review

References (94)

1. Sarkadi, B.; Szakas, G.; Varadi, A. http://www.sigmaaldrich.com/Area_of_interest/Drug_Discovery/ MultiDrug_Resistance/MDR_Review_Article.html
2. Fojo, A.T.; Ueda, K.; Slamon, D.J.; Poplack, D.G.; Gottesman, M.M.; Pastan, I. Proc. Natl. Acad. Sci. USA 1987, 84(1), 265.
3. Fojo, A.T.; Shen, D.W.; Mickley, L.A.; Pastan, I.; Gottesman, M.M. J. Clon. Oncol. 1987, 12(5), 1922.
4. Ueda, K.; Clark, D.P.; Chen, C.J.; Roninson, I.B.; Gottesman, M.M.; Pastan, I. J. Biol. Chem. 1987, 262(2), 505.
5. Young, R.C. Drug resistance: the clinical problem. In Drug Resistance in Cancer Therapy; Ozols, E.R.F., Ed.; Kluwer Academic Press: Boston, 1989, pp. 1-12.
6. Seelig, A.; Blatter, X.L.; Wohnsland, F. Int. J. Clin. Pharmacol. Ther 2000, 38(3), 11.
7. Vallabheneni, V.R.; Dahlheimer, J.L.; Bardgett, M.E.; Snyder, A.Z.; Finch, R.A.; Sartorelli, A.C.; Piwnica-Worms, D. Proc. Natl. Acad. Sci. USA 1999, 96, 3900.
8. Fromm, M.F. Int. J. Clin. Pharmacol. Ther. 2000, 38(2), 69.
9. Schinkel, A.H. Semin. Cancer Biol. 1997, 8, 161.
10. Goldstein, M.M.; Galski, H.; Fojo, A.; Willingham, M.; Lai, S.L.; Gazdak, A.; Pirker, R.; Cossman, J.; Gottesman, M.M.; Pastan, I. J. Natl. Cancer Inst. 1989, 81, 116.
11. Berger, D. Citarella, R.; Dutia, M.; Greenberger, L.; Hallett, W.; Paul, R.; Powell, D. J. Med. Chem. 1999, 42(12), 2145.
12. Tishler, D.M.; Weinberg, K.R.; Hinton, D.R.; Barbaro, N.; Annett, G.M.; Raffel, C. Epilepsia, 1995, 36(1), 1.
13. Lazarowski, A.; Sevlever, G.: Taratuto, A.; Massaro, M.; Rabinowicz, A. Pediatr. Neurol. 1999, 21, 731.
14. Dombrowski, S.M.; Desai, S.Y.; Marroni, M.; Cucullo, L.; Goodrich, K.; Bingaman, W. Mayberg, M.R.; Bangez, L.; Janigro, D. Epilepsia, 2001, 42(12), 1501.
15. Potschka, H.; Loscher, W. Epilepsia, 2001, 42(10), 1231.
16. Potschka, H.; Loscher, W. NeuroReport, 2001, 12(11), 2387.
17. Potschka, H.; Fedrowitz, M.; Loscher, W. NeuroReport, 2001, 12(16), 3557.
18. Sisodiya, S.M.; Lin, W.-R.; Squier, M.W.; Thom, M. Lancet, 2001, 357, 42.
19. Seegers, U.; Potschka, H.; Loscher, W. Epilepsia, 2002, 43(7), 675.
20. Seegers, U.; Potschka, H.; Loscher, W. Epilepsy Res. 2002, 51(3), 257.
21. Seegers, U.; Potschka, H.; Loscher, W. Eur. J. Pharmacol. 2002, 451, 149.
22. Kwan, P.; Sills, G.J.; Butler, E.; Gant, T.W.; Meldrum, B.S.; Brodie, M.J. Epilepsia, 2002, 43(11), 1318.
23. Sisodiya, S.M.; Lin, W.-R.; Harding, B.N.; Squier, M.V.; Thom, M. Brain, 2002, 125, 22.
24. Potschka, H.; Fedrowitz, M.; Loscher, W. Neurosci. Lett. 2002, 327(3), 173.
25. Rizzi, M.; Caccia, S.; Guiso, G.; Richichi, C.; Gorter, J.A.; Aronica, E.; Aliprandi, M.; Bagnati, R.; Fanelli, R.; D'Incalci, M.; Samanin, R.; Vezzani, A. J. Neurosci. 2002, 22(14), 5833.
26. Sander, J.M. The problem of the drug-resistant epilepsies. In Mechanisms of Drug Resistance in Epilepsy. Lessons from Oncology. Wiley, Chichester (Novartis Foundation symposium 243), 2002, pp. 4-19.
27. Abbott, N.J.; Khan, E.U.; Rollinson, C.M.S.; Reichel, A.; Janigro, D.; Dombrowski, S.M.; Dobbie, M.S.; Begley, D.J. Drug resistance in epilepsy: the role of the blood-brain barrier. In Mechanisms of Drug Resistance in Epilepsy. Lessons from Oncology. Wiley, Chichester (Novartis Foundation symposium 243), 2002, pp. 39-53.
28. Regesta, G.; Tanganelli, P. Epilepsy Res. 1999, 34, 109.
29. Loscher, W.; Schmidt, D. Epilepsy Res. 2002, 50, 3.
30. Loscher, W.; Potschka, H. J. Pharmacol. Exp. Ther. 2001, 301(1), 7.
31. Potschka, H.; Fedrowitz, M ; Loscher, W. J. Pharmacol. Exp. Ther. 2003, 306(1), 124.
32. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1981, 41, 1967.
33. Tsuruo, T. Circumvention of drug resistance with calcium channel blockers and monoclonal antibodies. In Drug Resistance in Cancer Therapy; Ozols, E.R.F., Ed.; Kluwer Academic Press: Boston, 1989, pp. 73-95.
34. Nogae, I.; Kohno, K.; Kikuchi, J.; Kuwano, M.; Akiyama, S.; Kiue, A.; Suzuki, K.; Yoshida, Y.; Cornwell, M.M.; Pastan, I.; Cottesman, M.M. Biochem. Pharmacol. 1989, 38, 519.
35. Shudo, N.; Mizoguchi, T.; Arita, M.; Yoshimura, A.; Seto, K.; Sakoda, R.; Akiyama, S. Cancer Res. 1990, 50, 3055.
36. Zamora, J.M.; Pearce, H.L.; Beck, W.T. Mol. Pharmacol. 1988, 33, 454.
37. Tsuruo, T.; Iida, H.; Kitatani, Y.; Yokota, K.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1984, 44, 4303.
38. Slater, L.M.; Sweet, P.; Stupecky, M.; Gupta, S. J. Clin. Invest. 1986, 77, 1405.
39. Kuntebommanahalli, N.T; Horton, J.K.; Seshadri, R.; Israel, M.; Houghton, J.A.; Harwood, F.C.; Houghton, P.J. J. Med. Chem. 1992, 35, 3358.
40. Tsuruo, T.; Iida, H.; Tsukagoshi, S.; Sakurai, Y. Cancer Res. 1982, 42, 4730.
41. Dhainaut, A.; Regnier, G.; Atassi, G.; Pierre, A.; Leonce, S.; Kraus-Berthier, L.; Prost, J.-F. J. Med. Chem. 1992, 35, 2481.
42. Hyafil, F.; Vergely, C.; Duvignaud, P.; Grandperret, T. Cancer Res. 1993, 53, 4595.
43. Germann, U.A.; Shlyakhter, D.: Mason, V.S.; Zelle, R.E.; Duff, J.P.; Galullo, V.; Armistead, D.M.; Saunders, J.O.; Boger, J.; Harding, M.W. Anticancer Drugs, 1997, 8(2), 125.
44. MacLogP Program, Version 4.0. BioByte Corp., Claremont, CA 91711, USA.
45. Robert, J. Drugs Future, 1998, 22, 149.
46. Greenberger, L.M.; Collins, K.I.; Annable, T.; Boni, J.P.; May, M.K.; Lai, F.M.; Kramer, R.; Citerella, R.V.; Hallett, W.A.; Powell, D. Oncol. Res. 1996, 8, 207.
47. Shinoda, H.; Inaba, M.; Tsuruo, T. Cancer Res. 1989, 49, 1722.
48. Pirker, R.; Keilhauer, G.; Raschack, M.; Lechner, C.; Ludwig, H. Int. J. Cancer 1990, 45, 916.
49. Toffoli, G.; Simone, F.; Corona, G.; Raschack, M.; Cappelleto, B.; Gigante, M.; Boiocchi, M. Biochem. Pharmacol. 1995, 50, 1245.
50. Boesch, D.; Gaveriaux, C.; Jachnes, B.; Poutier-Manzanedo, A.; Bollinger, P.; Loor, F. Cancer Res. 1991, 51, 4226.
51. Seelig, A. Eur. J. Biochem. 1998, 251, 252.
52. Cole, S.P.; Bhardwaj, G.; Gerlach, J.H.; Mackie, J.E.; Grant, C.E.; Almquist, K.C.; Stewart, A.J.; Kurz, E.U.; Duncan, A.M.; Deeley, R.G. Science 1982, 258, 1650.
53. Gottesman, M.M.; Pastan, I. Ann. Rev. Biochem. 1993, 62, 385.
54. Zhang, X.; Collins, K.I.; Greenberger, L.M. J. Biol. Chem. 1995, 270, 5441.
55. http://us.expasy.org/
56. Bakos, E.; Hegedus, T.; Hollo, Z.; Welker, E.; Tusnady, G.E.; Zaman, G.J.R.; Flens, M.J.; Varadi, A.; Sarkadi, B. J. Biol. Chem. 1996, 271, 12322.
57. Hipfner, D.R.; Almquist, K.C.; Leslie, E.M.; Gerlach, J.H.; Grant, C.E.; Deeley, R.G.; Cole, S.P.C. J. Biol. Chem. 1997, 272, 23623.
58. Beck, W.T.; Cirtain, M.C.; Glover, C.J.; Felsted, R.L.; Safa, A.R. Biochem. Biophys. Res. Commun. 1988, 153, 959.
59. Schinkel, A.H.; Wagenaar, E.; Mol, C.A.; van Deemter, L. J. Clin. Invest. 1996, 97, 2517.
60. Bakos, E.; Evers, R.; Szakacs, G.; Tusnady, G.E.; Welker, E.; Szabo, K.; de Haas, M.; van Deemter, L.; Borst, P.; Varadi, A.; Sarkadi, B. J. Biol. Chem. 1998, 273, 32167.
61. Priebe, W.; Krawczyk, M.; Kuo, M.T.; Yamane, Y.; Savaraj, N.; Ishikawa, T. Biochem. Biophys. Res. Commun. 1998, 247, 859.
62. Edafiogho, I.O.; Hinko, C.N.; Chang, H.; Moore, J.A.; Mulzac, D.; Nicholson, J.M.; Scott, K.R. J. Med. Chem. 1992, 35, 2798.
63. Mulzac, D.; Scott, K.R. Epilepsia 1993, 34, 1141.
64. Nicholson, J.M.; Edafiogho, I.O.; Moore, J.A.; Farrar, V.A.; Scott, K.R. J. Pharm. Sci. 1994, 83, 76.
65. Edafiogho, I.O.; Moore, J.A.; Farrar, V.A.; Nicholson, J.M.; Scott, K.R. J. Pharm. Sci. 1994, 83, 79.
66. Edafiogho, I.O.; Moore, J.A.; Alexander, M.S.; Scott, K.R. J. Pharm. Sci. 1994, 83, 1155.
67. Edafiogho, I.O.; Alexander, M.S.; Moore, J.A.; Farrar, V.A.; Scott, K.R. Curr. Med. Chem. 1994, 1, 159.
68. Scott, K.R.; Edafiogho, I.O.; Richardson, E.L.; Farrar, V.A.; Moore, J.A.; Tietz, E.I.; Hinko, C.N.; Chang, E.; El-Assadi, A.; Nicholson, J.M. J. Med. Chem. 1993, 36, 1947.
69. Scott, K.R.; Rankin, G.O.; Stables, J.P.; Alexander, M.S.; Edafiogho, I.O.; Farrar, V.A.; Kolen, K.R.; Moore, J.A.; Sims, L.D.; Tonnu, A.D.; Scott, K.R. J. Med. Chem. 1995, 38, 4033.
70. Laws, M.L.; Roberts, R.R.; Nicholson, J.M.; Butcher, R.; Stables, J.P., Goodwin, A.M.; Smith, C.; Scott, K.R. Bioorg. Med. Chem. 1998, 6, 2289.
71. Foster, J.E.; Nicholson, J.M.; Butcher, R.; Stables, J.P.; Edafiogho, I.O.; Goodwin, A.M.; Henson, M.C.; Smith, C.A.; Scott, K.R. Bioorg. and Med. Chem. 1999, 7, 2415.
72. Eddington, N.D.; Cox, D.S.; Roberts, R.R.; Stables, J.P.; Powell, C.B.; Scott, K.R. Curr. Med. Chem. 2000, 7, 417.
73. Cox, D.S.; Du, J.; Scott, K.R.; Gao, H.; Eddington, N.D. J. Chromatogr. B 2000, 749, 191.
74. Cox, D.S.; Scott, K.R.; Gao, H.; Raje, S. ; Eddington, N.D. J. Pharm. Sci. 2001, 90, 1540.
75. Cox, D.S.; Gao, H.; Rajje, S.; Scott, K.R.; Eddington, N.D. Eur. J. Pharm. Biopharm. 2001, 52, 145.
76. Eddington, N.D.; Cox, D.S.; Roberts, R.R.; Butcher, R.J.; Edafiogho, I.O.; Stables, J.P.; Cooke, N.; Goodwin, A.M.; Smith, C.A.; Scott, K.R. Eur. J. Med. Chem. 2002, 37, 635.
77. Cox, D.S.; Scott, K.R.; Gao, H.; Eddington, N.D. J. Pharmacol. Exp. Ther. 2002, 302, 1096.
78. Eddington, N.D.; Cox, D.S.; Khurana, M.; Salama, N.N.; Stables, J.P.; Harrison, S.J.; Negussie, A.; Taylor, R.S.; Tran, U.Q.; Moore, J.A.; Barrow, J.C.; Scott, K.R. Eur. J. Med. Chem. 2003, 38, 49.
79. Khurana, K.; Salama, N.N.; Scott, K.R.; Nemieboka, N.N.; Bauer, K. Jr., Eddington, N.D. Biopharm. Drug Dispos. 2003, 24, 397.
80. Banks, W.A.; Kastin, A.J. Brain Res. Bull. 1985, 15, 287.
81. Van Bree, J.B.; de Boer, A.G.; Danhog, M.; Ginnsel, L.A.; Breimer, D.D. J. Pharmacol. Exp. Ther 1988, 247, 1233.
82. Zaman G.J.: Flens M.J.: van Leusden M.R.; de Haas M.; Mulder H.S.; Lankelma J.; Pinedo H.M.; Scheper R.J.; Baas F.; Broxterman, H.J. Proc. Natl. Acad. Sci. USA 1994, 91, 8822.
83. Kool M.; de Haas M.; Scheffer G.L; Scheper R.J.; van Eijk M.J.; Juijn, J.A.; Baas F.; Borst, P. Cancer Res. 1996, 57, 3537.
84. Kool M.; van der Linden M.; de Haas M.; Scheffer G.L.; de Vree J.M.; Smith A.J.; Jansen G.; Peters G.J.; Ponne N.; Scheper R.J.; Elferink R.P.; Baas F.; Borst, P. Proc. Natl. Acad. Sci. USA 1999, 96, 6914.
85. Zhang Y.; Han H.; Elmquist W.F.; Miller, D.W. Brain Res. 2000, 876, 148.
86. Huai-Yun H.; Secrest D.T.; Mark K.S.; Carney D.; Brandquist C.; Elmquist W.F.; Miller, D.W. Biochem. Biophys. Res. Commun. 1998, 243, 816.
87. Adkison K.D.; Artru A.A.; Powers K.M.; Shen, D.D. J. Pharmacol. Exp. Ther. 1994, 268, 797.
88. Hollo Z.; Homolya L.; Hegedus T., Sarkadi, B. FEBS Lett. 1996, 383, 99.
89. Decleves X.; Regina A.; Laplanche J.L.; Roux F.; Boval B.; Launay, J.M.; Scherrmann, J.M. J. Neurosci. Res. 2000, 60, 594.
90. Borst, P.; Evers, R.; Kool, M.; Wijnholds, J. J. Natl. Cancer Inst. 2000, 92, 1295.
91. Schinkel, A.H. Adv. Drug Del. Rev. 1999, 36, 179.
92. Salama, NN.; Scott, K.R.; Eddington, N.D. Int. J. Pharm. 2004, 40, 1578.
93. Carson, J.R.; Carmosin, R.J.; Pitis, P.M.; Vaught, J.L.; Almond, H.R.; Stables, J.P.; Wolf, H.H.; Swinyard, E.A.; White, H.S. J. Med. Chem. 1997, 40, 1578.
94. CS ChemDraw Pro 4.5; Chem 3D Pro 4.0 for Macintosh, CambridgeSoft Corp. Cambridge, MA 02139 USA.